RS50013B - Himerni gen koji kodira antigene determinante četiri proteina l.infantum - Google Patents

Himerni gen koji kodira antigene determinante četiri proteina l.infantum

Info

Publication number
RS50013B
RS50013B YUP-516/01A YU51601A RS50013B RS 50013 B RS50013 B RS 50013B YU 51601 A YU51601 A YU 51601A RS 50013 B RS50013 B RS 50013B
Authority
RS
Serbia
Prior art keywords
infantum
proteins
gene encoding
chimeric gene
antigenic determinants
Prior art date
Application number
YUP-516/01A
Other languages
English (en)
Serbian (sr)
Inventor
Alonso Carlos Bedate
Original Assignee
C.B.F. Leti S.A.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C.B.F. Leti S.A., filed Critical C.B.F. Leti S.A.,
Publication of YU51601A publication Critical patent/YU51601A/sh
Publication of RS50013B publication Critical patent/RS50013B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
YUP-516/01A 1998-12-23 1999-12-23 Himerni gen koji kodira antigene determinante četiri proteina l.infantum RS50013B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11382598P 1998-12-23 1998-12-23
CA2256124A CA2256124C (en) 1998-12-23 1998-12-23 Chimeric gene formed of the dna sequences that encode the antigenic determinants of four proteins of l. infantum, and protein encoded by said gene, and pharmaceutical composition useful for preventing and/or treating leishmaniosis in animals or humans

Publications (2)

Publication Number Publication Date
YU51601A YU51601A (sh) 2005-07-19
RS50013B true RS50013B (sr) 2008-09-29

Family

ID=27671952

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-516/01A RS50013B (sr) 1998-12-23 1999-12-23 Himerni gen koji kodira antigene determinante četiri proteina l.infantum

Country Status (5)

Country Link
JP (1) JP4883839B2 (ja)
BR (1) BRPI9917863B8 (ja)
CA (1) CA2256124C (ja)
RS (1) RS50013B (ja)
ZA (1) ZA200105994B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR083829A1 (es) * 2010-11-10 2013-03-27 Leti S L Unipersonal Lab Coadyuvante con potencialidad inmunogenica incrementada

Also Published As

Publication number Publication date
BRPI9917863A2 (ja) 2010-12-21
ZA200105994B (en) 2002-07-22
JP2002533474A (ja) 2002-10-08
CA2256124A1 (en) 2000-06-23
CA2256124C (en) 2015-06-16
JP4883839B2 (ja) 2012-02-22
BRPI9917863C1 (pt) 2021-05-25
BRPI9917863B1 (pt) 2016-08-02
BRPI9917863B8 (pt) 2022-08-30
YU51601A (sh) 2005-07-19

Similar Documents

Publication Publication Date Title
KR0176265B1 (en) Causative agent of the mystery swine disease, and vaccine compositions
YU47735B (sh) Postupak za sintezu biološki aktivnih polipeptida limfotoksina
RS51157B (sr) Baff receptor (bcma), imunoregulatorni agens
ATE435661T1 (de) Adjuvant qs-21 enthaltende zusammensetzungen mit polysorbate oder cyclodextrin als hilfsmittel
EA200100447A1 (ru) Гибридные белки на основе бета-интерферона и их применение
DK0770397T3 (da) Newcastle disease viruskombinationsvaccine
EA200300137A1 (ru) Анти-il-12-антитела, композиции, способы и применения
DE69522216T2 (de) Zielzellen-bindende chimäre Peptide
DE69016956D1 (de) Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
LU93259I2 (fr) LETIFEND (Protein Q)
ATE46703T1 (de) Regionspezifische determinanten fuer vitamin-k abhaengiges knochenprotein.
RS50013B (sr) Himerni gen koji kodira antigene determinante četiri proteina l.infantum
AP9901666A0 (en) Leishmania vaccine.
DE69737476D1 (de) Neuer galaninrezeptor
SE8502540L (sv) Stabilt tandvardsmedel innehallande dextranas
ZA927199B (en) Chimeras of parainfluenza virus type 3 protein F and HN as vaccines.
CO4480058A1 (es) Genes codificantes y procedimiento de expresion de una nueva enzima: ftalil amidasa
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
DK292584D0 (da) Biologisk aktive konjugater, deres fremstilling og anvendelse
BR9810990A (pt) Dna-bactéria corineforme, e processos para produzir acido l-glutâmico, e, para produzir l-lisina e ácido l-glutâmico.
DE60138621D1 (de) Neuartige glykosyltransferase-gene
BR0013574A (pt) Antìgeno vacina de moraxella
DE69130675D1 (de) Klonierung und expression eines rhoptry-assoziierten proteins aus p. falciparum
YU48126B (sh) Postupak za pripremanje proteina plasmodium falciparum-a
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen